Hypertension Management in End-Stage Renal Disease (ESRD)
Blood Pressure Targets in ESRD
- For ESRD patients on dialysis, lowering both systolic and diastolic blood pressure has been shown to reduce cardiovascular events, cardiovascular death, and all-cause mortality, with the European Society of Cardiology suggesting this approach 1, 2
- While specific BP targets in ESRD remain somewhat controversial, evidence suggests aiming for SBP <140 mmHg as a reasonable target, as recommended by the European Heart Journal and Hypertension guidelines 1, 3
- In patients with ESRD who have undergone kidney transplantation, a BP goal of less than 130/80 mmHg is reasonable, according to the Hypertension guidelines 3
Pharmacological Management
Combination Therapy
- Calcium channel blockers combined with RAS blockers have shown superior efficacy in preventing doubling of serum creatinine and ESRD progression compared to thiazide diuretics with RAS blockers, as reported in the European Heart Journal 1, 2
- Loop diuretics should replace thiazides if serum creatinine is >1.5 mg/dL or eGFR is <30 mL/min/1.73 m², as suggested by the European Heart Journal 1
Special Considerations
- Avoid combination of two RAS blockers despite potentially greater antiproteinuric effects due to increased risk of adverse events, as warned by the European Heart Journal 1, 2
- Mineralocorticoid receptor antagonists are generally not recommended in ESRD, especially in combination with RAS blockers, due to risk of hyperkalemia, as advised by the European Heart Journal 1, 2
Monitoring and Follow-up
- Regular monitoring of serum potassium levels is essential, especially with RAS blockers, as emphasized by the European Heart Journal and Hypertension guidelines 1, 3
Hypertension Management in End-Stage Renal Disease (ESRD)
Blood Pressure Targets
- The American Heart Association recommends a blood pressure target of less than 130/80 mmHg for ESRD patients who have undergone kidney transplantation, to reduce cardiovascular events and mortality 4
First-Line Pharmacological Management
Renin-Angiotensin System (RAS) Blockers
- For patients who cannot tolerate ACE inhibitors, the American Diabetes Association and European Heart Association suggest ARBs as an appropriate alternative due to their cardioprotective effects 5, 6
Calcium Channel Blockers (CCBs)
- After kidney transplantation, CCBs are particularly beneficial due to improved GFR and kidney survival, as recommended by the American Heart Association 4
Monitoring and Safety Considerations
- The European Heart Association advises against the combination of two RAS blockers (ACE inhibitor plus ARB) due to increased risk of adverse events, despite potentially greater antiproteinuric effects 6
Hypertension Management in End-Stage Renal Failure
Blood Pressure Target
- The American College of Cardiology recommends a target blood pressure of <130/80 mmHg in ESRF patients, with evidence supporting even lower targets, particularly in those with proteinuria 7
- The European Society of Cardiology suggests avoiding systolic BP <120 mmHg in elderly patients (>65 years), where a range of 130-139 mmHg is more appropriate 8